(Q34569844)

3 August 2017

Cardiovascular drug use and the incidence of erectile dysfunction (English)

1 reference

3 August 2017

4

Auvinen A

1 reference

3 August 2017

Shiri R

1

1 reference

3 August 2017

Koskimäki J

2

1 reference

3 August 2017

Häkkinen J

3

1 reference

3 August 2017

Tammela TL

5

1 reference

3 August 2017

Hakama M

6

1 reference

3 August 2017

10 August 2006

1 reference

International Journal of Impotence Research

3 August 2017

1 reference

3 August 2017

19

1 reference

3 August 2017

208-212

1 reference

3 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ijir.3901516

3 August 2017

0 references

cites work

Incidence of erectile dysfunction in men 40 to 69 years old: results from a population-based cohort study in Brazil.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901516

Erectile dysfunction is a marker for cardiovascular disease: results of the minority health institute expert advisory panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901516

Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901516

Current drug use as risk factor for erectile dysfunction: results from an Italian epidemiological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901516

Drug therapy and prevalence of erectile dysfunction in the Massachusetts Male Aging Study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901516

Sexual dysfunction related to antihypertensive agents: results from the animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901516

Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901516

Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901516

Tissue angiotensin II as a modulator of erectile function. I. Angiotensin peptide content, secretion and effects in the corpus cavernosum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901516

Beta-blocker effects on sexual function in normal males

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901516

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901516

7 January 2021

Effect of chronic diseases on incidence of erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901516

7 January 2021

Association between the Bothersomeness of Lower Urinary Tract Symptoms and the Prevalence of Erectile Dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901516

7 January 2021

Effect of angiotensin II on corpus cavernosum smooth muscle in relation to nitric oxide environment: in vitro studies in canines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901516

7 January 2021

Identifiers

DOI

10.1038/SJ.IJIR.3901516

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference